Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue. - Wikidata - awgldk - TriplyDB

Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue.

Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue.

http://www.wikidata.org/entity/Q39741008

about

Gene therapy for skin diseases Cell therapy in dermatology.Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa.Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity Observations of skin grafts derived from keratinocytes expressing selectively engineered mutant laminin-332 molecules Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa.Bone marrow transplantation for recessive dystrophic epidermolysis bullosa Emerging technologies for gene manipulation in Drosophila melanogaster.Construction of transgenic Drosophila by using the site-specific integrase from phage phiC31 Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells.Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs).Stimulatory Effect of Autologous Adipose Tissue-Derived Stromal Cells in an Atelocollagen Matrix on Wound Healing in Diabetic db/db Mice.Keratin gene mutations in disorders of human skin and its appendages.Gene therapy of epidermolysis bullosa.Vesicobullous disorders of female genitalia.Current approaches and perspectives in human keratinocyte-based gene therapies.Gene editing toward the use of autologous therapies in recessive dystrophic epidermolysis bullosa.In Vivo Assessment of Engineered Skin Cell Delivery with Multimodal Optical Microscopy.Modelling cancer in human skin tissue.Gene therapy in combination with tissue engineering to treat epidermolysis bullosa.A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy.Gene therapy progress and prospects: the skin--easily accessible, but still far away.Lentiviral Engineered Fibroblasts Expressing Codon-Optimized COL7A1 Restore Anchoring Fibrils in RDEB.Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells Keratinocyte-/fibroblast-targeted rescue of Col7a1-disrupted mice and generation of an exact dystrophic epidermolysis bullosa model using a human COL7A1 mutation.Basement membranes and human disease.Allogeneic blood and bone marrow cells for the treatment of severe epidermolysis bullosa: repair of the extracellular matrix.Efficient in vivo gene editing using ribonucleoproteins in skin stem cells of recessive dystrophic epidermolysis bullosa mouse model.Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa.The long and winding road that leads to a cure for epidermolysis bullosa.Gene therapy: pursuing restoration of dermal adhesion in recessive dystrophic epidermolysis bullosa.Immortalized keratinocytes derived from patients with epidermolytic ichthyosis reproduce the disease phenotype: a useful in vitro model for testing new treatments.Immune reactivity to type VII collagen: implications for gene therapy of recessive dystrophic epidermolysis bullosa.SIN retroviral vectors expressing COL7A1 under human promoters for ex vivo gene therapy of recessive dystrophic epidermolysis bullosa.Intravenously injected recombinant human type VII collagen homes to skin wounds and restores skin integrity of dystrophic epidermolysis bullosa Long-term type VII collagen restoration to human epidermolysis bullosa skin tissue.Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients Injection of recombinant human type VII collagen restores collagen function in dystrophic epidermolysis bullosa.Fibroblast cell therapy enhances initial healing in recessive dystrophic epidermolysis bullosa wounds: results of a randomized, vehicle-controlled trial.Enhanced healing of mitomycin C-treated wounds in rats using inbred adipose tissue-derived stromal cells within an atelocollagen matrix.

P2860

Q26994703-4ED108F7-2F1F-4D11-BAC3-56513BCA5298 Q33653689-B1D06AD3-3AFA-4504-95BF-EBBB662A8208 Q33712943-94D573A7-AA91-4E7E-BC8B-E46FD7D97E51 Q33713926-79640B56-7BA4-4279-BD23-9A61517888BA Q33998351-7D992314-942A-415C-A727-4C1E576BBF9C Q34120479-2E6F5B09-0453-4A85-820F-397175B8F9F9 Q34256616-68E74603-F364-4661-BA21-58765FE2750A Q34398982-5891EA8F-65F1-4440-BCB8-C6CB90947BB2 Q34644225-26FB022F-0549-47B2-8A5B-CB4A3B086DE9 Q35008203-B18370DE-FE77-45A1-9804-3ADCC9C55217 Q35023324-D953D9B8-ABCF-4F09-A1D7-DD9AD45AA405 Q35104467-225A94B3-48B9-4406-BF30-B6F9EC680DAF Q35125858-F40D39DB-3551-497B-9350-D940AE1B3A03 Q35873767-DD7F0125-E5F1-4DDB-B9D3-1F6C27EF1E44 Q35890244-3607932C-7B32-457C-BD67-596C8B45DF0D Q35904434-D201B93A-9498-4EBA-BE77-9674B82D4C09 Q36326838-A6394A34-4694-44A4-8BF3-5CA67BC72EEF Q36399520-CBD1120F-9185-47FC-979D-9D3EDADD3496 Q36422870-8D46523C-0739-4BB1-AD2D-A2EA342732B4 Q36425931-3FA3F3CC-D17A-475B-9470-469949FC2EDD Q36512219-A59D9236-9239-448B-A862-4271EB86FEC1 Q36587586-90292217-FBD8-4A85-9775-229980C6AB7A Q36595683-65C645D0-055B-45BF-8394-421F38F3F576 Q37082009-10420620-3BBB-4DB6-B85C-A11700ACF3CC Q37462643-D7C2B47B-D277-4742-95D8-4F54D355798D Q37598031-FADCA1CE-1638-45E4-B6C5-BF046018FF8A Q37649276-A423DBE4-A128-4336-B278-30976CDC2570 Q37658980-7524698C-0796-483B-A584-DFD6F4E48FAC Q37712686-134832BB-22AB-4D2F-BD31-0E643D357068 Q38119245-72B8A1C7-E3A2-4C23-9E9C-18D58772BA1C Q38150897-AA3BE8FA-FBEC-498C-A5EA-C754B2D728A6 Q39639706-000FC7FA-0F90-43F1-B87A-824D3DEBD150 Q39884831-E1EB134D-A331-4423-BE83-FA501D2F867C Q41811020-DADB1A17-1826-498A-AFA3-96CC2FD0C8EB Q41868932-1FA9F5A2-C1AA-453A-9A84-C17EEA115D36 Q41956259-7D9E4D42-574B-423A-B366-FCDC01344887 Q42644106-396BB364-78E3-425A-AA66-F1AF3A1F679A Q45876048-C4A55B25-A5E2-4345-9E22-139311534F9C Q46860053-6B9CFDF0-02C0-444A-B26A-40D520DB4632 Q50952140-37866058-F30F-4235-BD14-14C1A4C22C73

P2860

Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue.

http://www.wikidata.org/entity/Q39741008

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Injection of genetically engin ...... ermolysis bullosa skin tissue.

@en

Injection of genetically engin ...... ermolysis bullosa skin tissue.

@nl

type

label

Injection of genetically engin ...... ermolysis bullosa skin tissue.

@en

Injection of genetically engin ...... ermolysis bullosa skin tissue.

@nl

prefLabel

Injection of genetically engin ...... ermolysis bullosa skin tissue.

@en

Injection of genetically engin ...... ermolysis bullosa skin tissue.

@nl

P1433

Q39741008-C457A33B-997F-4C6A-83FA-F7DB749FBB5A

P1476

Q39741008-685FA29A-D812-4715-82EC-E479FD258943

P2093

Q39741008-28B2A208-8669-40D9-82A6-E0B389990144

Q39741008-809B08EA-6386-4485-A9C9-4A3CB00FE0AC

Q39741008-8F4DC48C-2F77-458E-A816-32CBC5025B75

Q39741008-C0D07435-CA74-46B4-933B-7C46CCDEF4DF

Q39741008-C710C5E6-AD60-497D-831F-649D52EEC5C2

Q39741008-DB5EC1AD-9993-4CE4-9427-947D51528A28

P2860

Q39741008-07DF5BCB-6DBC-4DF4-9BD0-C03575277AE7

Q39741008-0EF68A22-FBFD-422F-8152-BBE7076489DC

Q39741008-130B8AB1-BDF8-43CD-B82F-A9F8337EFDC8

Q39741008-14AC5E51-64BD-42C6-9EF9-B2E3A017353D

Q39741008-1AD34DD6-A4EB-4BEC-8B4F-2D64E2775B48

Q39741008-2E8A563A-F8C6-415C-A93D-ACE1375B0653

Q39741008-3023A176-E6D5-45EB-A737-81A78EDF04A8

Q39741008-42C20F19-6FD2-4938-8C16-6F05DC7BF03A

Q39741008-4834B6AA-7BB7-4C1A-ADDD-AB00CCD3104B

Q39741008-4A461A4F-E8B9-4FC0-BFE1-7F5FBF83B491

P304

Q39741008-4FC2DB56-1D38-4FF3-9050-F2AB08486518

P31

Q39741008-23918821-5DA6-4EB3-B2E9-E778DFD00456

P356

Q39741008-8FDECD9A-11DA-41A9-B9A5-F0553D912184

P407

Q39741008-09968D79-84AF-444B-BCAB-6623EC942361

P433

Q39741008-632B2A1D-7E95-4941-92BF-DF875FF05E15

P478

Q39741008-9D733F52-7342-4830-8E86-9104D7697CE6

P577

Q39741008-1146C86B-F3CA-470C-AE13-0217D20EF892

P698

Q39741008-4FFE786F-CA63-433E-914E-8BB823BDD6B9

P932

Q39741008-88F658B3-62C7-4988-AB26-418949817FC3

P356

P1433

Journal of Clinical Investigation

P1476

Injection of genetically engin ...... ermolysis bullosa skin tissue.

@en

P2093

Cheryl L Green

http://www.w3.org/2001/XMLSchema#string

Douglas R Keene

http://www.w3.org/2001/XMLSchema#string

M Peter Marinkovich

http://www.w3.org/2001/XMLSchema#string

Paul A Khavari

http://www.w3.org/2001/XMLSchema#string

Qun Lin

http://www.w3.org/2001/XMLSchema#string

Susana Ortiz-Urda

http://www.w3.org/2001/XMLSchema#string

P2860

BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription

Type VII collagen forms an extended network of anchoring fibrils

Biology of anchoring fibrils: lessons from dystrophic epidermolysis bullosa.

Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase

Fibroblasts and dermal gene therapy: a minireview.

A model of corrective gene transfer in X-linked ichthyosis.

Cutaneous gene transfer for skin and systemic diseases.

In vivo restoration of laminin 5 beta 3 expression and function in junctional epidermolysis bullosa.

Transcriptional control in keratinocytes and fibroblasts using synthetic ligands.

Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants.

P304

251-255

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI200317193

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12531881

http://www.w3.org/2001/XMLSchema#string

P932

151880

http://www.w3.org/2001/XMLSchema#string